Cargando…
Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
Background: The antitumor and immunomodulating activities of melatonin are widely known. These activities are based upon the multifactorial mechanism of action on various links of carcinogenesis. In the present paper, the long-term results of the clinical use of melatonin in the combined treatment o...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566809/ https://www.ncbi.nlm.nih.gov/pubmed/33110479 http://dx.doi.org/10.18632/oncotarget.27757 |